Antiretroviral Drugs
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)contractFind a Tender ↗Ref ocds-h6vhtk-04ac3a32014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
10
Lots
1
10 awarded
Published
06 May 2025
Description
Antiretroviral Drugs
Scope
- Reference
- PAD-OJEU-57065
- Commercial tool
- Standalone contract
- Contract dates
- 30 Jun 2025 to 30 Jun 2028
Retendered after 3 year contract with an option to extend for 12months
- Main category
- goods
- Contract locations
- Wales
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Product Quality/Acceptability | Pass/Fail | quality | — |
| Financial (overall cost of contract) | 85 | quality | — |
| Social Value/Community Benefits | 15 | quality | — |
| Price | 65 | cost | — |
| Price stability | 20 | cost | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 10 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Award 1· 1 supplier
Awarded —
Award value
—
Award 2· 1 supplier
Awarded —
Award value
—
Award 3· 1 supplier
Awarded —
Award value
—
Award 4· 1 supplier
Awarded —
Award value
—
Award 5· 1 supplier
Awarded —
Award value
—
Award 6· 1 supplier
Awarded —
Award value
—
Award 7· 1 supplier
Awarded —
Award value
—
Award 8· 1 supplier
Awarded —
Award value
—
Award 9· 1 supplier
Awarded —
Award value
—
Award 10· 1 supplier
Awarded —
Award value
—
Other contracts from Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Amarox Pharma· 2
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Transitional Drugs 4 | contract | — | 25 Oct 2025 |
| Transitional Drugs 4 | contract | — | 05 Sept 2025 |